Home
  • 简体中文
  • 繁體中文
  • English
  • Svenska
  • Home
  • Health Care Professionals
  • Consumers
  • Partners
  • About BioGaia
  • News
  • Investors
Health Care Professionals / Clinical evidence
Printer-friendly version Send to friend
  • Increase
  • Decrease
  • Normal

Current Size: 100%

Other benefit areas

  • Allergy
  • Chemotherapy
  • Constipation
  • Diarrhoea, reduced risk of
  • Gut motility
  • Irritable bowel syndrome (IBS)
  • Lactose intolerance
  • Neonates in intensive care
  • Safety and colonisation
  • Clinical evidence
    • Acute diarrhoea
    • Antibiotic-associated diarrhoea (AAD)
    • Infant colic
    • General health
    • Helicobacter pylori
    • Oral health
    • Other benefit areas
      • Allergy
      • Chemotherapy
      • Constipation
      • Diarrhoea, reduced risk of
      • Gut motility
      • Irritable bowel syndrome (IBS)
      • Lactose intolerance
      • Neonates in intensive care
      • Safety and colonisation
  • L. reuteri basic facts
  • Documentation from scientific events
  • Basic research
  • Product quality and delivery system
  • Reviews
  • BioGaia Probiotic products

 

Find BioGaia products worldwide

Select your country

Watch video testimonial

Watch a short interview with Dr Francavilla, Dr Romano and Dr Steiber on Lactobacillus reuteri

Summaries of clinical studies

Download the summaries of clinical studies

CONTACT PAGE 
TERMS OF USE I COOKIES
BUSINESS & PARTNER
Lotta Johansson
lj@biogaia.se
RESEARCH
Eamonn Connolly
ec@biogaia.se
PRESS
Peter Rothschild
pr@biogaia.se
INVESTOR RELATIONS
Margareta Hagman
mh@biogaia.se